Collaborative Research Projects
As part of Gentian Health’s commitment to be at the forefront of medical device design, it views involvement and partnership in ground breaking research and commercialisation projects as being a key part of its organisational development and learning. To this end, Gentian Health has committed its long-term involvement and resources to a number of consortia made up of Third Level institutions and industry partners.
The following are some of the potentially life changing projects Gentian is partnered in:
Our third-level institutions and industry partners
EyeVU
The EyeVU consortium will work to deliver an innovative miniaturised “eyeball” camera for endoscopy which will allow clinicians to see around corners with unparalleled precision while also driving a first-in class sustainability solution for the MedTech Sector.
This project brings together world-class expertise in Ireland in Medical Device Design, Optics, Nano-Manufacturing and Medical Device Product Development.
This project is jointly funded under the Disruptive Technology Innovation Fund (DTIF) program.
Contact Gentian to learn more about EyeVU
lily
Gentian Health’s medical device product development team are working with Luminate Medical and NUIG to design and develop a breakthrough technology to end chemotherapy induced hair loss.
The lily consortium is working to develop a compression-based technology, that does not rely on freezing temperatures to prevent chemotherapy reaching the hair follicles in a portable and comfortable way.
This project is jointly funded under the Disruptive Technology Innovation Fund (DTIF) program.
Contact Gentian to learn more about lily
Releaze
A smart, patient centric, catheter-based solution for treating malignant pleural effusion in the home.
The vision of the consortium is to set a new standard of care for MPE treatment by providing a patient-centric drainage solution, called Releaze, that:
- Actively prevents fluid reaccumulating within 30 days
- Provides patients with autonomy in their care through user-centric design and a mobile Health (mHealth) approach
- Facilitate remote monitoring by clinicians thus reducing clinic hours
- Limits the risks posed to vulnerable patients by limiting the time they spend in hospital unnecessarily.
This project is jointly funded under the Disruptive Technology Innovation Fund (DTIF) program.
Contact Gentian to learn more about Releaze